Informativo

SFEVEREIRO, 2015

Combinação de Curcumin C3 Complex® e BioPerine® da Sabinsa usada em estudo publicado sobre síndrome metabólica

Combinação de Curcumin C3 Complex® e BioPerine® da Sabinsa usada em estudo publicado sobre síndrome metabólica

Informativo - 2015

Outro estudo significativo sobre a combinação de Curcumin C3 Complex® e BioPerine®, ®, efeitos de modificação de lipídios de terapia adjuvante com combinação de curcuminoides e piperina em pacientes com...

SJUNE, 2014

Sabinsa Awarded Four New International Patents

Sabinsa Awarded Four New International Patents

Newsletters - 2014

Sabinsa has received several new patents this year thus far, bringing the company's portfolio of patents to 91 internationally. Here are some patent highlights: Australian patent for the proprietary process...

Sabinsa’s Sister Company Sami Labs Enters Into Memorandum of Understanding With Arya Vaidya Sala to Further Ayurvedic Interests and Products

Sabinsa’s Sister Company Sami Labs Enters Into Memorandum of Understanding With Arya Vaidya Sala to Further Ayurvedic Interests and Products

Newsletters - 2014

Sabinsa' s sister company Sami Labs entered into a Memorandum of Understanding with India's premier Ayurvedic practice and research organization, Arya Vaidya Sala, Kottakkal (AVS), to further the use of...

Sabinsa / Sami Labs Licence Two Patents from Indian Institute of Integrative Medicine and The Indian Council of Medical Research

Sabinsa / Sami Labs Licence Two Patents from Indian Institute of Integrative Medicine and The Indian Council of Medical Research

Newsletters - 2014

The Indian Institute of Integrative Medicine (IIIM), the Indian Council of Medical Research (ICMR), and Sami Labs Limited, Sabinsa's sister company, have entered into a tripartite agreement whereby Sami and...

Sabinsa / Sami Labs Founder Writes Two Letters To Industry: IP Protection

Sabinsa / Sami Labs Founder Writes Two Letters To Industry: IP Protection

Newsletters - 2014

You've likely noticed that we have been talking a lot about Intellectual Property issues within the dietary supplements industry lately, not just in the United States, but abroad as well....

SOCTOBER, 2012

Sabinsa’s Saberry® + Cococin™ Formulation Granted US Patent

Sabinsa’s Saberry® + Cococin™ Formulation Granted US Patent

Newsletters - OCT 2012

Sabinsa Corporation’s SABERRY® + COCOCIN™ synergistic formulation has been granted US patent 8247003. Saberry® from Sabinsa Corporation is a proprietary extract from the fruits of Emblica officinalis (Phyllanthus emblica) or...

Sabinsa’s Curcumin C3 Complex® Shows Significant Reduction In Serum Triglycerides

Sabinsa’s Curcumin C3 Complex® Shows Significant Reduction In Serum Triglycerides

Newsletters - OCT 2012

A placebo-controlled, randomized double-blind clinical trial published in Phytotherapy Research titled Effects of Supplementation with Curcuminoids on Dyslipidemia in Obese Patients: A Randomized Crossover Trial (Mohammadi et al, 2012) reported...

Sabinsa’s LactoSpore® Chosen For Tutti Frutti, World's Top Selling Self-Serve Frozen Yogurt

Sabinsa’s LactoSpore® Chosen For Tutti Frutti, World's Top Selling Self-Serve Frozen Yogurt

Newsletters - OCT 2012

Sabinsa’s LactoSpore® has been selected by Wellspring Industry, Inc. to provide the beneficial probiotic ingredient for Tutti Frutti Frozen Yogurt, the world’s top-selling self-serve frozen yogurt brand.“The taste and quality...

A Case of Unscientific Product Development, Promotion and Commercialization in The Curcumin Market

A Case of Unscientific Product Development, Promotion and Commercialization in The Curcumin Market

Newsletters - OCT 2012

What is BCM-95®† / Biocurcumax™* Standardization of BCM-95®/ BIOCURCUMAX™ Curcuminoids Complex with volatile compounds : Not less than 95% Indian patent on Biocurcumax™ Year 2002-Indian Patent Application filed at Chennai...

Book on Tetrahydrocurcuminoids - C3 Reduct®

Book on Tetrahydrocurcuminoids - C3 Reduct®

Newsletters - OCT 2012

Tetrahydrocurcuminoids are among the major metabolites of curcuminoids irrespective of mode of administration. The recent discovery that intestinal organisms in human gut possess specific enzymes for metabolizing curcuminoids into Tetrahydrocurcuminoids...

SAUGUST, 2012

Sabinsa Granted Patent on Tetrapure®

Sabinsa Granted Patent on Tetrapure®

Newsletters - AUG 2012

Sabinsa has been granted the company’s 70th patent on February 21, 2012. This US patent, #US 8,119,696 is entitled Treatment of superficial and cutaneous mycoses with a pure form of...

Sabinsa’s Shaheen Majeed Speaks on Natural Preservatives at HBA Global Expo

Sabinsa’s Shaheen Majeed Speaks on Natural Preservatives at HBA Global Expo

Newsletters - AUG 2012

Shaheen Majeed, Marketing Director, Sabinsa Corp. was a panelist discussing Green BioActives: New Technology Trends for Ingredients on Tuesday June 19, 2012 from 1 - 2 PM as part of...

Sabinsa Receives Payment From Creative Compounds For ForsLean® Trademark Infringement

Sabinsa Receives Payment From Creative Compounds For ForsLean® Trademark Infringement

Newsletters - AUG 2012

An intellectual property battle lasting three years and reaching the US Supreme Court has ended at last with payment to Sabinsa Corporation by Creative Compounds of all profits made through...

Sabinsa Receives Award for Best Marketing: Curcumin C3 Complex®

Sabinsa Receives Award for Best Marketing: Curcumin C3 Complex®

Newsletters - AUG 2012

When the editors of Functional Ingredients, with help from editors of Nutrition Business Journal, scoured the show floor the first day at Engredia 2012 to find the best of the...

SNOVEMBER, 2011

Sabinsa Awarded Damages by US District Court on ForsLean®

Sabinsa Awarded Damages by US District Court on ForsLean®

Newsletters - 2011

Creative Compounds Ordered To Pay For ForsLean® Trademark Infringement August 08, 2011- Sabinsa Corporation has been awarded damages for Creative Compound's ForsLean® trademark infringement by the US District Court of...

01 Novembro 2011
Sabinsa's BioPerine® Validated I Resveratrol Pre-Clincal Study

Sabinsa's BioPerine® Validated I Resveratrol Pre-Clincal Study

Newsletters - 2011

August 16, 2011- A study published in the August Volume of Molecular Nutrition & Food Research (Special Issue: Resveratrol - Current Status and Outlook) entitled Enhancing the bioavailability of resveratrol...

01 Novembro 2011
SupplySide West: New Products

SupplySide West: New Products

Newsletters - 2011

October 11, 2011- Sabinsa Corporation highlighted innovative products at SupplySide West, at the Sands Expo Center, Las Vegas October 12 - 13, 2011. Pterostilbene and Curcumin are two ingredients whose...

01 Novembro 2011
Sabinsa on Wheels in Australia: Target Inflammation

Sabinsa on Wheels in Australia: Target Inflammation

Newsletters - 2011

In continuation of our tradition, this year Sabinsa Australia hosted Sabinsa on Wheels (SOW) program in Sydney, against beautiful backdrop of Manly beach at Novotel, on 26th October 2011. This...

01 Novembro 2011

As informações atuais apresentadas no Boletim "Edições Atuais" da Sabinsa Corporation são apenas para fins informativos.
Ele é abstraído de fontes da web e mídia impressa. Os leitores são aconselhados a consultar as fontes originais para obter informações adicionais.

    VISIT US

  • Edifício Koerich Beiramar Office
    Avenida Mauro Ramos
    1970- Sala 705-Centro
    Florianópolis-SC
    Brasil CEP 88.020-302

  • +55 48 3206 3682
  • info@sabinsa.com.br

Certificados

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

Fale Conosco